Orion Pharma SRL
21.6 FTEOrion Pharma reported revenue of €4.44m for the 2025 financial year (annual accounts filed with the NBB on 20 Aug 2026), with 21.6 full-time equivalents.
The score of Orion Pharma shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Revenue -1 % Equity +76 % Total assets +60 % Headcount (avg FTE) +227 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Orion Pharma's annual accounts
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Revenue | €4.44m | ||||
| Net result | 137,817 € | ||||
| Equity | 822,015 € | ||||
| Cash | 427,711 € | ||||
| EBITDA | 282,141 € | ||||
| Total assets | €1.22m |
Filed annual accounts
- Year ended 31 Dec 2025filed on 20 Aug 2026
- Year ended 31 Dec 2024filed on 01 Jul 2025
- Year ended 31 Dec 2023filed on 31 Jul 2024
- Year ended 31 Dec 2022filed on 29 Sep 2023
- Year ended 31 Dec 2021filed on 19 Jul 2022
Orion Pharma's financial analysis
- Solvency67.6%sector median: 46.0%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Orion Pharma
Orion Pharma's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0821.527.741
- VAT number
- BE0821527741
- Peppol
- Registered · 0208:0821527741 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 17 Dec 2009
- Registered office
- 2800 Mechelen
- Size
- Small · 21.6 FTE
- Latest accounts
- 2025 · filed on 20 Aug 2026
- Activity
- Wholesale of pharmaceutical and medical goods (NACE 46460)
Orion Pharma (SRL) has been based in Mechelen since 2009, active in: wholesale of pharmaceutical and medical goods. For 2025, it reports revenue of €4.44m, a net profit of 137,817 € and equity of 822,015 €. With 21.6 full-time equivalents, it is a small enterprise by headcount. Its solvency stands at 67.6%, above the median of its sector (46.0%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to Orion Pharma
Companies in the same business, of comparable size and area, outside its group.
- Laboratoires Bailleul Wholesale of pharmaceutical and medical goods Anderlecht · balance sheet €2.45m
- Green 2 Manufacture of basic pharmaceutical products Ostend · balance sheet €2.01m
- ASM Services & Consulting Market research and public opinion polling Hasselt · balance sheet 590,643 €
- DS Consult Market research and public opinion polling Bilzen-Hoeselt · balance sheet 499,103 €
- Ecomar Wholesale of pharmaceutical and medical goods Ath · balance sheet €1.36m
- Theramex Belgium Activities of agents involved in non-specialised wholesale Ghent · balance sheet €1.14m
- Yvsolab Wholesale of pharmaceutical and medical goods Turnhout · balance sheet €1.99m
- SERGE HUGARD MANAGEMENT CONSULTING, en abrégé S.H.M.C. Wholesale of pharmaceutical and medical goods Mont-Saint-Guibert · balance sheet €1.67m
Frequently asked questions about Orion Pharma
What is the revenue of Orion Pharma?
According to the 2025 annual accounts filed with the NBB, the revenue of Orion Pharma amounts to 4,437,772 €.
What is the VAT number of Orion Pharma?
In Belgium, the VAT number is the company number prefixed with BE: BE0821527741 for Orion Pharma, if the company is VAT-registered. Its company number (CBE) is 0821.527.741.
Where is the registered office of Orion Pharma?
According to the CBE register, the registered office of Orion Pharma is in 2800 Mechelen.
What is the equity of Orion Pharma?
At the close of the 2025 financial year, the equity of Orion Pharma amounts to 822,015 €, a solvency of 67.6% of total assets.
How many people work at Orion Pharma?
21.6 full-time equivalents on average according to the 2025 social balance sheet.
Who manages Orion Pharma?
The register lists 2 active mandates at Orion Pharma. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Orion Pharma
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →